Jim Cramer: Buy This Financial Stock, 'I Think They're High Quality'

Zinger Key Points
  • Cramer praised Moelis & Co. "I work with them, I know them, I think they’re high quality," he noted.
  • Cramer said "stay away" from pharma and biotech firm Catalent.

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Vishay Intertechnology, Inc. VSH is "way too cheap." He added, "This is one of those moments where I think you’ve got to buy Vishay."

Cramer also recommended buying Abbott Laboratories ABT. "Abbot Labs has gotten way too cheap," he noted.

Cramer said Moelis & Company MC has come down too much and recommended buying the same. "I work with them, I know them, I think they’re high quality," he noted.

See Also: EXCLUSIVE - Jim Cramer Recommended SVB Financial In February, An Example Of 'His Reverse Midas Touch'

The "Mad Money" host said Riot Platforms, Inc. RIOT doesn’t make any money. "If you want to do Bitcoin BTC/USD, own Bitcoin," he added.

Cramer recommended selling Anheuser-Busch InBev SA/NV BUD and buying Constellation Brands, Inc. STZ.

Cramer said "stay away" from pharma and biotech firm Catalent, Inc. CTLT.

Don’t forget to check out our premarket coverage here

Price Action: Shares of Catalent gained 0.3% to close at $39.57, while Anheuser-Busch fell 0.3% to $62.61 on Wednesday. Constellation fell 1.6% to $237.95, while Riot Platforms rose 1.1% to $13.00 during Wednesday’s session. Moelis & Company gained 1.7% to $47.11, while Abbott Laboratories shares rose 1.5% to settle at $103.63. Vishay Intertechnology shares rose 0.4% on Wednesday.
Now Read This: How To Earn $500 A Month From NVIDIA Stock After Last Week's Strong Earnings Report

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!